<?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2014//EN" "http://www.ncbi.nlm.nih.gov/corehtml/query/DTD/pubmed_140101.dtd">
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">30203374</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>02</Month>
            <Day>26</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>02</Month>
            <Day>26</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1432-198X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>34</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>01</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Pediatric nephrology (Berlin, Germany)</Title>
                <ISOAbbreviation>Pediatr Nephrol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Cinacalcet as rescue therapy for refractory hyperparathyroidism in young children with advanced chronic kidney disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>129-135</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00467-018-4055-7</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND">Studies in the use of the calcimimetic, cinacalcet, in pediatric chronic kidney disease (CKD) are few and limited to older children with secondary hyperparathyroidism (sHPT), a major morbid complication contributing to poor growth, bone deformities, and cardiovascular disease. Our objectives were to determine a safe and effective dosing regimen of cinacalcet in the treatment of infants and young children with sHPT that was refractory to standard care and to examine their growth during treatment.</AbstractText>
                <AbstractText Label="METHODS">Ten young pediatric patients with advanced CKD were studied retrospectively during 11 courses of treatment with cinacalcet. All had severe sHPT with intact parathyroid hormone (iPTH) levels â¥â500Â pg/ml and were refractory to standard therapy with phosphate binders and active vitamin D analogs at high doses for &gt;â30Â days. The cinacalcet dose was advanced by 50% every 2-4Â weeks to achieve a decline in the iPTH to a goal of 150-300Â pg/ml. Linear growth was assessed at 6-month intervals by change in z-scores (â³SDS) for length before and during cinacalcet therapy.</AbstractText>
                <AbstractText Label="RESULTS">Median age at initiation of cinacalcet was 18Â months (IQR 6, 36) with an average starting dose of 0.7âÂ±â0.2Â mg/kg/day. Median effective dose required to reach iPTH goal of 150-300Â pg/ml was 2.8Â mg/kg/day (IQR 2.0, 3.1), and time to goal was 112Â days (IQR 56, 259) with a median overall decline in iPTH of 82% from baseline by 6Â months (pâ&lt;â0.0001). No subject experienced a clinical adverse event, although 4 had biochemical asymptomatic hypocalcemia. Linear growth improved significantly during cinacalcet therapy (â³SDS -â0.62âÂ±â1.2 versus +â0.91âÂ±â1.4; pâ&lt;â0.005). By multiple regression analysis, the primary determinants of growth were concurrent treatment with growth hormone and age &lt;â2Â years (R<sup>2</sup>â=â89.6%; pâ&lt;â0.001). A shorter treatment time required to achieve iPTH goals also was associated with improved growth (râ=â-â0.75; pâ&lt;â0.01).</AbstractText>
                <AbstractText Label="CONCLUSIONS">Cinacalcet may be used effectively and safely in infants and small children with refractory sHPT in advanced CKD using a cautious dosing regimen. Cinacalcet successfully brings iPTH to target level and supports growth when other treatments have been ineffective.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Arenas Morales</LastName>
                    <ForeName>Aura J</ForeName>
                    <Initials>AJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pediatric Nephrology, Holtz Children's Hospital, University of Miami, P.O. Box 016960, Miami, FL, 33130, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>DeFreitas</LastName>
                    <ForeName>Marissa J</ForeName>
                    <Initials>MJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pediatric Nephrology, Holtz Children's Hospital, University of Miami, P.O. Box 016960, Miami, FL, 33130, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Katsoufis</LastName>
                    <ForeName>Chryso P</ForeName>
                    <Initials>CP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pediatric Nephrology, Holtz Children's Hospital, University of Miami, P.O. Box 016960, Miami, FL, 33130, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Seeherunvong</LastName>
                    <ForeName>Wacharee</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pediatric Nephrology, Holtz Children's Hospital, University of Miami, P.O. Box 016960, Miami, FL, 33130, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chandar</LastName>
                    <ForeName>Jayanthi</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pediatric Nephrology, Holtz Children's Hospital, University of Miami, P.O. Box 016960, Miami, FL, 33130, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zilleruelo</LastName>
                    <ForeName>Gaston</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pediatric Nephrology, Holtz Children's Hospital, University of Miami, P.O. Box 016960, Miami, FL, 33130, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Freundlich</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pediatric Nephrology, Holtz Children's Hospital, University of Miami, P.O. Box 016960, Miami, FL, 33130, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Abitbol</LastName>
                    <ForeName>Carolyn L</ForeName>
                    <Initials>CL</Initials>
                    <Identifier Source="ORCID">0000-0002-0984-3771</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Pediatric Nephrology, Holtz Children's Hospital, University of Miami, P.O. Box 016960, Miami, FL, 33130, USA. cabitbol@med.miami.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>09</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>Pediatr Nephrol</MedlineTA>
            <NlmUniqueID>8708728</NlmUniqueID>
            <ISSNLinking>0931-041X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D057966">Calcimimetic Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D010281">Parathyroid Hormone</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>UAZ6V7728S</RegistryNumber>
                <NameOfSubstance UI="D000069449">Cinacalcet</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D057966" MajorTopicYN="N">Calcimimetic Agents</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000069449" MajorTopicYN="N">Cinacalcet</DescriptorName>
                <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004351" MajorTopicYN="N">Drug Resistance</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006962" MajorTopicYN="N">Hyperparathyroidism, Secondary</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007676" MajorTopicYN="N">Kidney Failure, Chronic</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010281" MajorTopicYN="N">Parathyroid Hormone</DescriptorName>
                <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Calcimimetic</Keyword>
            <Keyword MajorTopicYN="Y">Cinacalcet</Keyword>
            <Keyword MajorTopicYN="Y">Growth</Keyword>
            <Keyword MajorTopicYN="Y">Hyperparathyroidism</Keyword>
            <Keyword MajorTopicYN="Y">Pediatric chronic kidney disease</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>02</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>08</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2018</Year>
                <Month>08</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>9</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>2</Month>
                <Day>27</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2018</Year>
                <Month>9</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">30203374</ArticleId>
            <ArticleId IdType="doi">10.1007/s00467-018-4055-7</ArticleId>
            <ArticleId IdType="pii">10.1007/s00467-018-4055-7</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Nephrol Dial Transplant. 2009 Mar;24(3):926-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18840894</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Nephrol. 2013 Apr;28(4):537-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22893310</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin J Am Soc Nephrol. 2008 May;3(3):658-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18256372</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FASEB J. 2004 Jan;18(1):143-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14597561</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Bone Miner Res. 2013 May;28(5):992-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23212715</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Nephrol. 2008 Feb;23(2):179-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18043947</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Nephrol. 2010 Sep;25(9):1747-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20495831</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Endocrinol Metab. 2013 Dec;98(12):4834-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24108314</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 1994 Jan;45(1):253-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8127016</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nephrol Dial Transplant. 2008 Sep;23(9):2761-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18408076</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2013 May 8;309(18):1921-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23645144</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Medicine (Baltimore). 2015 Jan;94(2):e401</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25590845</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatrics. 2002 May;109(5):909-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11986455</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Nephrol. 2008 Oct;23(10):1721-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18594867</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Nephrol. 2010 Jan;25(1):143-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19838738</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatrics. 2017 Dec;140(6):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29192005</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Nephrol. 2017 Jul;32(7):1103-1108</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28451892</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Nephrol. 2016 May;31(5):795-800</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26628282</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Kidney Int. 1994 Oct;46(4):1160-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7861712</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Nephrol. 2008 Oct;23(10):1817-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18288502</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Nephrol. 2017 Jul;32(7):1221-1232</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28332096</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Nephrol. 2008 Oct;23(10):1823-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18504621</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>